EBV Infection After Allogenic HSCT
2 clinical trials · Condition
◉ Watch EBV Infection After Allogenic HSCT
| Record | Firm | Date |
|---|---|---|
| Prevention of Epstein-Barr Virus Reactivation With the ATG-based Haploidentical Protocol Combined With Rituximab in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (NCT07693881) | Nanfang Hospital, Southern Medical University | 2026-07-01 |
| Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT (NCT06119256) | Chinese PLA General Hospital | 2023-08-01 |
Track EBV Infection After Allogenic HSCT automatically
Every clearance here is in the API, with alerts when new ones post.